These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30538756)

  • 21. WITHDRAWN: Insulin-sensitising drugs for polycystic ovary syndrome.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003053. PubMed ID: 19588338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome.
    Li J; Ren J; Sun W
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():13-21. PubMed ID: 27923166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of Qingre Yangyin Recipe on Endocrine and Metabolism of Polycystic Ovary Syndrome Patients].
    Zhang T
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1175-80. PubMed ID: 26677666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.
    Zhang J; Li T; Zhou L; Tang L; Xu L; Wu T; Lim DC
    Cochrane Database Syst Rev; 2010 Sep; (9):CD007535. PubMed ID: 20824862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2010 Jan; (1):CD003053. PubMed ID: 20091537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of placebo-controlled insulin-sensitizing drugs on hormonal parameters in polycystic ovary syndrome patients: A network meta-analysis.
    Huang R; Zhao PF; Xu JH; Liu DD; Luo FD; Dai YH
    J Cell Biochem; 2018 Mar; 119(3):2501-2511. PubMed ID: 28941255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial.
    Kuek S; Wang WJ; Gui SQ
    Zhong Xi Yi Jie He Xue Bao; 2011 Sep; 9(9):965-72. PubMed ID: 21906521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.
    Wang R; Li W; Bordewijk EM; Legro RS; Zhang H; Wu X; Gao J; Morin-Papunen L; Homburg R; König TE; Moll E; Kar S; Huang W; Johnson NP; Amer SA; Vegetti W; Palomba S; Falbo A; Özmen Ü; Nazik H; Williams CD; Federica G; Lord J; Sahin Y; Bhattacharya S; Norman RJ; van Wely M; Mol BW; ;
    Hum Reprod Update; 2019 Nov; 25(6):717-732. PubMed ID: 31647106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003053. PubMed ID: 19821299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of cinnamon supplementation on glycemic control in women with polycystic ovary syndrome: A systematic review and meta-analysis.
    Heshmati J; Sepidarkish M; Morvaridzadeh M; Farsi F; Tripathi N; Razavi M; Rezaeinejad M
    J Food Biochem; 2021 Jan; 45(1):e13543. PubMed ID: 33111340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetyl-L-Carnitine Ameliorates Metabolic and Endocrine Alterations in Women with PCOS: A Double-Blind Randomized Clinical Trial.
    Tauqir S; Israr M; Rauf B; Malik MO; Habib SH; Shah FA; Usman M; Raza MA; Shah I; Badshah H; Ehtesham E; Shah M
    Adv Ther; 2021 Jul; 38(7):3842-3856. PubMed ID: 34047916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2012 May; (5):CD003053. PubMed ID: 22592687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials.
    Almalki HH; Alshibani TM; Alhifany AA; Almohammed OA
    BMC Womens Health; 2020 Apr; 20(1):68. PubMed ID: 32248801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kuntai Capsule Combined With Letrozole on Gonadal Hormone Levels and Ovarian Function in Patients With PCOS: A Systematic Review and Meta-Analysis.
    Tang X; Huang Q; Wang C; Zhang D; Dong S; Yu C
    Front Endocrinol (Lausanne); 2021; 12():789909. PubMed ID: 35027910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Metformin on Reproductive, Endocrine, and Metabolic Characteristics of Female Offspring in a Rat Model of Letrozole-Induced Polycystic Ovarian Syndrome With Insulin Resistance.
    Xie Y; Xiao L; Li S
    Front Endocrinol (Lausanne); 2021; 12():701590. PubMed ID: 34484117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders: A Prospective Randomized Control Trial.
    Wang QY; Song Y; Huang W; Xiao L; Wang QS; Feng GM
    Chin Med J (Engl); 2016 Apr; 129(8):883-90. PubMed ID: 27064030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies.
    Behboudi-Gandevani S; Ramezani Tehrani F; Rostami Dovom M; Farahmand M; Bahri Khomami M; Noroozzadeh M; Kabir A; Azizi F
    Gynecol Endocrinol; 2016; 32(5):343-53. PubMed ID: 27052492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment.
    An Y; Sun Z; Zhang Y; Liu B; Guan Y; Lu M
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):425-31. PubMed ID: 23869585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
    Lord JM; Flight IH; Norman RJ
    Cochrane Database Syst Rev; 2003; (3):CD003053. PubMed ID: 12917943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.